musculoskeletal health
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.
The San Francisco-based musculoskeletal care platform will be included in Cigna’s offerings for self-insured employers.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.